Erasca, Inc. 86,486,486 Shares of Common Stock, par value $0.0001 per share Underwriting AgreementErasca, Inc. • May 17th, 2024 • Pharmaceutical preparations • New York
Erasca, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“JPM”) and BofA Securities, Inc. (“BofA”) are acting as representatives (the “Representatives”), an aggregate of 86,486,486 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 12,972,972 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
